Internal Medicine, Endocrinology, Diabetes, & Metabolism · Columbus, OH
NPI
1306893433
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
72 W 3rd Ave
Columbus, OH, 43201
Phone (614) 453-9999
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
333 services
Medicare patients, 2024
101
Average age 71
Drug cost, 2024
$2.0M
1,725 prescriptions
Company payments, 2025
$428K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elena A Christofides was code 99214 (office e&m - established), 165 times for 53 patients. In total Elena A Christofides billed 333 services in 10 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 165 | 53 | $85.08 | $14K |
| 99215 Office E&M - Established | Office | 133 | 74 | $111.78 | $15K |
| 99205 Office E&M - New | Office | 17 | 17 | $133.64 | $2,272 |
By year: 2022 $23K for 265 services; 2023 $33K for 325 services; 2024 $32K for 333 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 14 | 12 | $8.40 | $118 |
Medicare prescription drug claims, 2024
In 2024, the drug Elena A Christofides prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 126 prescriptions and refills. In total Elena A Christofides wrote 1,725 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 126 | 288 | 34 | $13K |
| Pioglitazone Hcl Generic | 124 | 296 | 36 | $1,870 |
| Progesterone Progesterone, Micronized | 108 | 215 | 27 | $4,312 |
| Ozempic Semaglutide | 88 | 114 | 14 | $107K |
| Mounjaro Tirzepatide | 79 | 103 | 22 | $105K |
| Estradiol Generic | 76 | 136 | 19 | $1,106 |
| Jardiance Empagliflozin | 66 | 117 | 15 | $68K |
| Liothyronine Sodium Generic | 65 | 165 | 20 | $3,013 |
| Atorvastatin Calcium Generic | 48 | 144 | 15 | $808 |
| Estradiol (Twice Weekly) Estradiol | 48 | 75 | 16 | $3,098 |
| Metformin Hcl Generic | 45 | 97 | 11 | $264 |
| Isturisa Osilodrostat Phosphate | 39 | 39 | Under 11 | $567K |
| Omega-3 Acid Ethyl Esters Generic | 38 | 101 | 11 | $2,585 |
| Metformin Hcl Er Metformin Hcl | 35 | 97 | Under 11 | $645 |
| Recorlev Levoketoconazole | 33 | 33 | Under 11 | $606K |
Brand drugs: 775 claims; generic drugs: 925 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elena A Christofides $428K ($424K in general payments such as food, travel and fees and $3,982 for research) from 28 companies. The largest payer was Recordati_rare_diseases_inc. with $95K.
| Company | Payments | Amount |
|---|---|---|
| Recordati_rare_diseases_inc. | 115 | $95K |
| Corcept Therapeutics CORT | 103 | $92K |
| Ascendis Pharma Endocrinology Inc ASND | 131 | $86K |
| Xeris Pharmaceuticals, Inc. | 88 | $80K |
| Chiesi USA, Inc. | 22 | $26K |
| Lilly USA, LLC LLY | 23 | $22K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 19 | $18K |
| Madrigal Pharmaceuticals MDGL | 12 | $5,818 |
| Abbott Laboratories ABT | 3 | $2,719 |
| Alexion Pharmaceuticals, Inc. AZN | 5 | $746 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.